Search

eDoctor inaugurates 5th batch for out-of-practice female doctors

admin 02:31 PM, 14 Nov, 2019
KARACHI: Female doctors who have been out of practice can now apply for the Dow University’s online re-certification courses starting from December.

The university is accepting applications for its fifth batch of eDoctor, an online platform meant to bring female doctors back into the medical field. Classes are expected to start from December 25. Applications close on November 25.

Participants have a chance to get a CME-accredited certification in Family Medicine. Courses will be in the disciplines of neurology, gynaecology, ophthalmology, psychiatry, dermatology, paediatrics, and internal medicine.

Those who wish to enroll in the program are required to either upload their CV, recent photographs, medical degree, CNIC, and PMDC registration certificate on the eDoctor portal on the DUHS website or send an email to edoctor@duhs.edu.pk or send the documents via WhatsApp on 923008259933.

The dissolution of the Pakistan Medical and Dental Council will not affect the application procedure, said Abdullah Butt, CEO, Educast.

Educast is an online teaching platform, which in collaboration with the Dow University of Health Sciences, runs virtual certification programs for women who have been out of touch with the profession to address the shortage of female doctors in the country.

Currently, eDoctor has around 700 registered female doctors from Pakistan and 20 other countries, including North America, Saudi Arabia, UAE, Australia, and the UK.

Classes for its fourth batch began in September 2019 and will conclude in March 2020. A six-month online course in Therapeutics and e-Prescription was supposed to start in August but has been postponed to December.

“The program was designed in a way that catered more to academics. However, doctors from remote areas, overseas, and housewives were more interested in being given practical knowledge and learning from case studies and pharmacological guides; therefore, we restructured the program,” Dr Butt said.

The training will be carried out by Dow’s Pharmacology Department, and the clinical faculty will deal with participants’ questions and answers.

-PR